Bladder cancer

NEW --- Molecular diagnostics in the era of targeted therapies for mUCa

Earn accreditation points

Finish 5 case(s) answer 10 question(s) and Earn 1 credit.

Continue
Освітня мета: Assess the relevance of molecular tumour testing to guide the management of metastatic urothelial carcinoma (mUCa). Recognise molecular biomarkers, sample types and molecular assays to employ molecular tumour testing for mUCa.
Спеціальність: Medical oncology, urology, clinical oncology
Цільова аудиторія: Specialists (CME: intermediate, advanced), Residents (senior)
Останнє оновлення: May 2024
Фон:

Regulatory approval status of drugs and companion diagnostics included in this topic (indications limited to the mUCa setting, status 3 April 2024)